Psyence Biomedical Ltd (PBM) Stock Price, Quote & News

Company Profile

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress dis...

Industry: Biotechnology

Sector: Healthcare

Phone: 416 346 7764

Website: www.psyencebiomed.com

Address:

121 Richmond Street West, Penthouse Suite, 1300, Toronto, Canada

Vikingsstrade Oct. 3 at 7:43 PM

$WAI $SLGL $PTIX $PBM Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.

0 · Reply

DM0n3y Oct. 3 at 4:40 PM

$SNGX $PBM $IMUX $CTMX

0 · Reply

HouseOfTheDragons Oct. 3 at 2:53 AM

Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $BNZI $TBLT $PBM $AGRI floats

0 · Reply

MoonCowBoy Oct. 3 at 12:54 AM

$SLGL $PTIX $PBM $NIVF "

0 · Reply

MexaTraders Oct. 2 at 8:16 PM

Ticker ASTC is starting to move. 6.40$ break could send ASTC into a potential HALT-up or squeeze. It is breaking out and starting its 300% run now! Can we see a massive run of ASTC into close? Micro float Squeezer is making a move! $LASE $APVO $PBM $RAYA !!

0 · Reply

1Spartantrade1 Oct. 2 at 6:44 PM

Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $PTIX $PBM $NIVF $LITM

0 · Reply

Tradetime3472 Oct. 2 at 3:56 PM

$PBM Im a bull but I don’t think this is accurate anymore. They are a little behind probably more like 1H 2026 now..still super undervalued here , $10 is nothing compared to peers

1 · Reply

YouVSYou Oct. 2 at 3:42 PM

$PBM $10 target 🎯 swing

1 · Reply

PhishTourFunds Oct. 2 at 3:41 PM

$PBM

0 · Reply

YouVSYou Oct. 2 at 3:27 PM

$PBM this is going to be a fun one

1 · Reply

Psyence BioMed to Present at the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025

Jul 31, 2025, 7:30 AM EDT - 2 months ago

Psyence BioMed's Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production

Jun 25, 2025, 5:00 PM EDT - 3 months ago

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

Jun 18, 2025, 5:36 PM EDT - 3 months ago

PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares

Jun 18, 2025, 8:30 AM EDT - 3 months ago

Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025

Jun 17, 2025, 8:00 AM EDT - 3 months ago

Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements

May 27, 2025, 7:30 AM EDT - 4 months ago

Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial

May 1, 2025, 7:30 AM EDT - 5 months ago

Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split

Apr 17, 2025, 7:17 PM EDT - 6 months ago

Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Apr 17, 2025, 9:39 AM EDT - 6 months ago

Psyence Group Announces Share Consolidation

Apr 15, 2025, 8:30 AM EDT - 6 months ago

Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement

Apr 8, 2025, 8:00 AM EDT - 6 months ago

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

Mar 31, 2025, 8:00 AM EDT - 6 months ago

Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing

Mar 18, 2025, 8:30 AM EDT - 7 months ago

Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein

Mar 10, 2025, 11:18 AM EDT - 7 months ago

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D.

Feb 26, 2025, 8:00 AM EST - 7 months ago

Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D.

Dec 27, 2024, 4:05 PM EST - 10 months ago

Psyence Biomed Announces Closing of $2.0 Million Private Placement

Dec 23, 2024, 7:30 AM EST - 10 months ago

Psyence Biomedical Regains Full Compliance with All Nasdaq Continued Listing Requirements

Dec 17, 2024, 8:37 AM EST - 10 months ago

Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial

Dec 17, 2024, 7:30 AM EST - 10 months ago

Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial

Dec 10, 2024, 7:30 AM EST - 10 months ago

Psyence Biomed Executes Binding Agreements with Optimi Health Corp.

Dec 6, 2024, 11:06 AM EST - 10 months ago

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

Dec 3, 2024, 7:30 AM EST - 10 months ago

Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

Nov 19, 2024, 4:05 PM EST - 11 months ago

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation

Nov 12, 2024, 4:30 PM EST - 11 months ago

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq

Oct 31, 2024, 9:30 AM EDT - 1 year ago

Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs

Oct 25, 2024, 9:42 AM EDT - 1 year ago

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

Oct 24, 2024, 7:00 AM EDT - 1 year ago

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development

Oct 14, 2024, 10:43 AM EDT - 1 year ago

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical

Oct 4, 2024, 4:05 PM EDT - 1 year ago

Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant

Sep 20, 2024, 11:20 AM EDT - 1 year ago

Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs

Sep 19, 2024, 7:30 AM EDT - 1 year ago

Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs

Sep 18, 2024, 9:30 AM EDT - 1 year ago

Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones

Sep 16, 2024, 9:31 AM EDT - 1 year ago

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones

Sep 13, 2024, 4:30 PM EDT - 1 year ago

Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq

Sep 9, 2024, 7:30 AM EDT - 1 year ago

Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care

Sep 6, 2024, 7:30 AM EDT - 1 year ago

Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant

Aug 30, 2024, 7:00 AM EDT - 1 year ago

Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC

Aug 27, 2024, 4:05 PM EDT - 1 year ago

Psyence Biomed to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024

Aug 13, 2024, 7:30 AM EDT - 1 year ago

Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Psyence Biomed Enters Into $25 Million Common Stock Purchase Agreement with White Lion Capital, LLC

Jul 26, 2024, 9:30 AM EDT - 1 year ago

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial

Jul 24, 2024, 4:05 PM EDT - 1 year ago

Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial

Jul 3, 2024, 8:34 PM EDT - 1 year ago

Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

May 17, 2024, 7:00 AM EDT - 1 year ago

Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

Apr 17, 2024, 8:00 AM EDT - 1 year ago

Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)

Apr 16, 2024, 11:01 AM EDT - 1 year ago

Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Apr 8, 2024, 8:00 AM EDT - 1 year ago

Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Vikingsstrade Oct. 3 at 7:43 PM

0 · Reply

DM0n3y Oct. 3 at 4:40 PM

$SNGX $PBM $IMUX $CTMX

0 · Reply

HouseOfTheDragons Oct. 3 at 2:53 AM

0 · Reply

MoonCowBoy Oct. 3 at 12:54 AM

$SLGL $PTIX $PBM $NIVF "

0 · Reply

MexaTraders Oct. 2 at 8:16 PM

0 · Reply

1Spartantrade1 Oct. 2 at 6:44 PM

0 · Reply

Tradetime3472 Oct. 2 at 3:56 PM

$PBM Im a bull but I don’t think this is accurate anymore. They are a little behind probably more like 1H 2026 now..still super undervalued here , $10 is nothing compared to peers

1 · Reply

YouVSYou Oct. 2 at 3:42 PM

$PBM $10 target 🎯 swing

1 · Reply

PhishTourFunds Oct. 2 at 3:41 PM

$PBM

0 · Reply

YouVSYou Oct. 2 at 3:27 PM

$PBM this is going to be a fun one

1 · Reply

topstockalerts Oct. 1 at 8:52 PM

After Hours Top Gainers PT2 $ARBB $TAOP $GIFI $PBM $PFSA

0 · Reply

Tradetime3472 Oct. 1 at 8:38 PM

$PBM I hate when penny flippers get in this..where the long term investors at

0 · Reply

Rounderssss4 Oct. 1 at 8:25 PM

$PBM 👀

0 · Reply

MyPreciousShares Oct. 1 at 6:41 PM

$PBM added some here. Long hold. I don’t expect results until Q2 26 but we could have several positive news events in between

1 · Reply

TradingRunners Sep. 30 at 8:48 PM

Wow what is happening to MTEX right now!? Seems like ALL volume and momentum are shifting into MTEX!! Could it be the next crazy runner of the day?? Bulls should keep it on watch - MTEX is breaking out! Also watching: $LASE $APVO $PBM $RAYA nx

0 · Reply

majd900 Sep. 29 at 9:24 PM

$IXHL 💡 Big things ahead: 3 drugs in the works (sleep apnea, anxiety, arthritis) → huge markets Trials show strong results so far. Cash at $73M = plenty of runway Still early stage + some dilution, but if even 1 drug gets approved, this could be a game changer 🚀 Competitors mentioned: $CMPS $CYBN $PBM LET’s get it🔥💥

0 · Reply

VolcanicTrades Sep. 29 at 3:42 PM

$PBM keep an eye on it. Nice dip this morning. Under $3 adds

0 · Reply

JD101 Sep. 28 at 11:03 PM

$PBM loafing zone again

1 · Reply

StockHounding Sep. 28 at 6:11 PM

$PAVS worldwide breakout watch All the big boys are commenting on its move AH!! 🔥🔥🔥🔥🔥🔥⏰🔥🔥🔥🔥🔥🔥 $PHIO sleeping for too long $GP keeps eyes $PBM proverbial bottom $ZNB almost a go

0 · Reply

LegendaryCharts Sep. 28 at 2:51 PM

$PAVS Top of the watchlist for me, Micro float starting its massive run! Could go crazy! $GANX Begins Its GT-02287 Phase 1b Extension $PBM round 2 due soon with $APVO t+10

0 · Reply

Tradetime3472 Sep. 27 at 8:23 PM

$PBM I think we got big news on the ibogaine front..I hope bottom has been reached https://www.marijuanamoment.net/former-gop-house-speaker-promotes-cutting-edge-science-of-the-psychedelic-ibogaine/

0 · Reply

Neggudgid Sep. 26 at 5:17 PM

$PBM I guess we’re allowed to go up now. How nice.

0 · Reply

Market Cap	6.01M
Revenue (ttm)	0.00
Net Income (ttm)	1.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	59,200
Avg Vol	2,601,348
Day's Range	N/A - N/A
Shares Out	1.87M
Stochastic %K	34%
Beta	0.24
Analysts	Strong Buy
Price Target	N/A